FDA AMENDED_483 - fusion iv pharmaceuticals, inc. - December 02, 2019
FDA AMENDED_483 for fusion iv pharmaceuticals, inc. on December 02, 2019. Product: Devices. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA AMENDED_483 for fusion iv pharmaceuticals, inc. on December 02, 2019. Product: Devices. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
December 2, 2019
Product Type
Devices
ID: cf825ad2-2b01-4ae3-8c4e-44a78d7120d0
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox